EXAS · As filed with the SEC

Exact Sciences balance sheet, by quarter

The statement as Exact Sciences presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.

Consolidated Balance Sheets · USD thousands

USD thousands	Q4 2025 Dec 31, 2025	Q3 2025 Sep 30, 2025	Q2 2025 Jun 30, 2025	Q1 2025 Mar 31, 2025	Q4 2024 Dec 31, 2024	Q3 2024 Sep 30, 2024	Q2 2024 Jun 30, 2024	Q1 2024 Mar 31, 2024
ASSETS
Current assets:
Cash and cash equivalents	955,996	789,037	657,099	347,127	600,889	588,830	530,180	347,487
Marketable securities	8,715	214,058	201,336	439,048	437,137	432,301	416,602	304,606
Accounts receivable, net	298,653	306,051	353,335	279,800	248,968	264,819	263,865	240,584
Inventory	166,201	164,784	171,499	176,574	162,383	136,987	127,373	128,534
Prepaid expenses and other current assets	126,284	116,796	124,590	127,792	122,046	110,180	114,467	99,059
Total current assets	1,555,849	1,590,726	1,507,859	1,370,341	1,571,423	1,533,117	1,452,487	1,120,270
Long-term assets:
Property, plant and equipment, net	—	—	—	—	—	690,332	703,083	702,041
Property, plant and equipment, net	708,664	704,065	705,105	697,907	693,673	—	—	—
Operating lease right-of-use assets	122,332	121,114	126,106	126,659	116,952	122,452	139,807	142,017
Goodwill	2,368,048	2,368,028	2,368,021	2,367,111	2,366,676	2,367,450	2,366,972	2,367,052
Intangible assets, net	919,925	941,200	965,370	988,873	1,009,693	1,864,399	1,843,478	1,866,856
Other long-term assets, net	185,811	174,876	124,904	160,182	169,722	170,821	167,468	178,085
Total assets	5,860,629	5,900,009	5,797,365	5,711,073	5,928,139	6,748,571	6,673,295	6,376,321
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	175,868	129,356	157,324	142,175	89,572	97,653	52,980	60,498
Accrued liabilities	416,473	408,774	317,154	295,137	328,292	313,997	302,540	265,121
Operating lease liabilities, current portion	33,591	31,851	31,338	29,808	27,405	27,170	27,096	27,225
Other current liabilities	15,220	14,279	16,117	35,345	37,765	35,804	37,103	33,455
Loans Payable, Current	—	—	—	—	0	0	0	50,000
Convertible Notes Payable, Current	0	0	0	0	249,153	249,038	248,923	248,810
Total current liabilities	641,152	584,260	521,933	502,465	732,187	723,662	668,642	685,109
Convertible notes, net, less current portion	2,327,177	2,325,637	2,324,097	2,322,574	2,321,067	2,319,490	2,317,948	2,066,805
Other long-term liabilities	329,317	324,807	315,899	320,225	315,503	332,213	326,678	329,384
Operating lease liabilities, less current portion	161,931	163,886	166,022	168,902	157,133	162,695	167,665	162,405
Total liabilities	3,459,577	3,398,590	3,327,951	3,314,166	3,525,890	3,538,060	3,480,933	3,243,703
Stockholders’ equity:
Preferred stock, $0.01 par value Authorized—5,000,000 shares issued and outstanding—no shares at December 31, 2025 and December 31, 2024	0	0	0	0	0	0	0	0
Common stock, $0.01 par value Authorized—400,000,000 shares issued and outstanding—190,802,322 and 185,616,438 shares at December 31, 2025 and December 31, 2024	1,909	1,896	1,893	1,887	1,857	1,852	1,848	1,839
Additional paid-in capital	7,102,766	7,116,306	7,064,867	6,993,254	6,899,368	6,837,476	6,786,668	6,710,681
Accumulated other comprehensive income (loss)	2,358	3,243	3,086	1,013	(944)	4,630	(943)	(499)
Accumulated deficit	(4,705,981)	(4,620,026)	(4,600,432)	(4,599,247)	(4,498,032)	(3,633,447)	(3,595,211)	(3,579,403)
Total stockholders’ equity	2,401,052	2,501,419	2,469,414	2,396,907	2,402,249	3,210,511	3,192,362	3,132,618
Total liabilities and stockholders’ equity	5,860,629	5,900,009	5,797,365	5,711,073	5,928,139	6,748,571	6,673,295	6,376,321

As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.